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DObjective: Patients with single-ventricle heart disease experience early and late failure during and after staged
palliation. Little is known about the factors related to continued risk of transplantation and mortality after com-
pletion of staged palliation. The long-term outcome of patients with single-ventricle diseasewho require a gastric
fundoplication early in life has not been assessed.
Methods:A total of 155 patients with single-ventricle disease who survived their first-stage palliative procedure
were enrolled in a research registry. Demographic and anatomic variables were collected, and the families were
contacted every 6 months for prospective documentation of transplant-free survival. Medical records were re-
viewed for the details of noncardiac surgical procedures. Univariate and multivariate regression analyses
were performed to determine the impact of early gastric surgery on late transplant-free survival.
Results: There were 93 male patients, median gestational age was 38 weeks, and birth weight was 3.2 kg. Sixty-
five patients (42%) had hypoplastic left heart syndrome. Twelve patients (7.7%) had a genetic syndrome.
Thirty-two patients (21%) had a fundoplication or a gastrostomy tube at less than 2 years of age. Median
follow-up was 4.3 years (range, 79 days to 10 years). Race, gender, gestational age, birth weight, and genetic
syndrome did not alter midterm transplant-free survival. Need for fundoplication or gastrostomy was an inde-
pendent risk factor for decreased transplant-free survival (P ¼ .003; hazard ratio, 4.29), which was unchanged
when adjusted for all covariates.
Conclusions: The need for early fundoplication or gastrostomy is associated with decreased transplant-free
survival for patients with palliated single-ventricle heart disease. (J Thorac Cardiovasc Surg 2012;143:891-5)Earn CME credits at
http://cme.ctsnetjournals.org
Widespread clinical evidence has demonstrated improving
outcomes for infants born with single-ventricle disease, in-
cluding hypoplastic left heart syndrome (HLHS).1,2
Specifically, several studies have shown reduced early
mortality after both the Norwood and Fontan procedures
over the past 2 decades.2-4 Despite improved early survival,
patients with single-ventricle heart disease have been shown
to have ongoing attrition long after Fontan completion.3 To
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pletion of staged palliation.
Children with single-ventricle disease are complex pa-
tients even beyond the scope of their cardiovascular pathol-
ogy. As a result, they often require noncardiac surgery. The
most commonly performed noncardiac surgical procedures
in this population are Nissen fundoplication, gastrostomy
tube (GT) placement, circumcision, and partial resection
of the small intestine.5 The literature is contradictory with
regard to the perioperative risk of noncardiac procedures
in this patient population, with reports ranging between
zero mortality for laparoscopic procedures and 19% mor-
tality associated with even minor procedures.5,6 More
important, the long-term outcome of patients with single-
ventricle disease who require noncardiac surgery early in
life has not been reported.
The purpose of this study was to investigate the effect of
early Nissen fundoplication or GTon the midterm outcomes
for children with single-ventricle heart disease.
MATERIALS AND METHODS
Institutional review board approval was obtained to create a registry of
patients with single-ventricle heart disease born between May 1999 and
September 2007 who presented to Children’s Healthcare of Atlanta at
Egleston for cardiac catheterization before second-stage palliation. All of
the patients were survivors of first-stage palliation. Patients who underwent
primary transplant rather than staged palliation and those whose parents
refused consent were excluded from the study.rdiovascular Surgery c Volume 143, Number 4 891
TABLE 1. Patient demographics and preoperative clinical
characteristics
Characteristic
Overall
N ¼ 155
No fundo/GT
N ¼ 123
Fundo/GT
N ¼ 32
P
value
Race
White (%) 94 (61) 76 (62) 18 (56) .84
 Black (%) 36 (23) 28 (23) 8 (25)
 Hispanic (%) 25 (16) 19 (16) 6 (19)
Female gender (%) 62 (60) 46 (37) 16 (50) .19
Ventricular morphology
 Left (%) 56 (36) 51 (42) 5 (16) .008
 Right (%) 88 (57) 62 (51) 26 (81)
 Both (%) 10 (7) 9 (7) 1 (3)
Diagnosis*
 HLHS (%) 65 (42) 41 (33) 24 (75) .002
 DILV (%) 17 (11) 16 (13) 1 (3)
 Hypo RV/TA/PA (%) 30 (20) 3 (22) 3 (9)
 Unbalanced
CACV (%)
8 (5) 7 (6) 1 (3)
 Heterotaxy (%) 9 (6) 7 (6) 2 (6)
 Other (%) 25 (16) 24 (20) 1 (3)
HLHS (%) 65 (42) 41 (33) 24 (75) <.001
Gestational age (SD)* 38.2 (2.0) 38.2 (2.1) 38.1 (1.8) .71
Birth weight (SD)* 3.2 (0.6) 3.2 (0.6) 3.2 (0.5) .70
Genetic syndrome (%) 12 (8) 9 (7) 3 (9) .70
HLHS, Hypoplastic left heart syndrome; DILV, double-inlet left ventricle; hypo
RV/TA/PA, hypoplastic right ventricle with tricuspid or pulmonary atresia; CAVC,
complete atrioventricular canal defect; fundo/GT, fundoplication or gastrostomy
tube. *Contains some missing data.
Abbreviations and Acronyms
GERD ¼ gastroesophageal reflux disease
GT ¼ gastrostomy tube
HLHS ¼ hypoplastic left heart syndrome
HR ¼ hazard ratio
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DDemographic data were collected, including gender, race, cardiac diag-
nosis, presence of a genetic syndrome, gestational age, and birth weight.
We also determined the dates of fundoplication or GT procedures. Family
members were contacted every 6 months for prospective follow-up of clin-
ical status. The typical timing of staged palliation at Children’s Healthcare
of Atlanta includes second-stage palliation (bidirectional Glenn shunt or
hemi-Fontan procedure) at 4 to 6 months of age followed by Fontan com-
pletion (lateral tunnel or extracardiac conduit, generally fenestrated in ei-
ther case) between 2 and 4 years of age. The timing and type of cardiac
surgical procedures chosen were determined by surgeon and cardiologists’
preferences. The indications for and timing of noncardiac procedures were
abstracted from the medical record.
Statistical Analysis
An initial bivariate analysis was performed to identify (1) risk factors
associated with an increased incidence of fundoplication or GT and (2)
risk factors associated with long-term transplant-free survival (using
Kaplan–Meier analysis and Cox proportional hazards regression models).
To estimate the independent effect of fundoplication or GT on survival,
we constructed amultivariable extended Coxmodel that adjusted for all po-
tential confounders determined to be associated with both incidence of fun-
doplication or GT and long-term transplant-free survival. Fundo/GT was
modeled as a time-dependent covariate, because it is a variablewhose value
can change over the course of the study period. Hazard ratios (HRs) and
95% confidence intervals were estimated for each effect, including the
primary study effect (fundoplication or GT).
All statistical tests were evaluated at the 0.05 alpha level. Analyses were
performed using SAS version 9.2 (SAS Institute Inc, Cary, NC). No adjust-
ments for multiple comparisons were made.RESULTS
Of the 155 patients, 32 (21%) had a fundoplication or GT
before 2 years of age. Patient demographics are shown in
Table 1. It should be noted that patients were not routinely
evaluated by a geneticist. Genetic evaluation was initiated
on clinical grounds, such as multiorgan anomalies or the
presence of dysmorphic features. Also included in Table 1
is the bivariate analysis of association between these preop-
erative variables and the performance of a fundoplication or
GT. Ventricular morphology and cardiac diagnosis were
significantly related to the incidence of fundoplication or
GT (P ¼ .008 and .002, respectively) with a greater need
for fundoplication or GT in patients with a dominant right
ventricle in general or HLHS in particular.Indication, Timing, and Type of Gastric Surgery
The majority of patients who underwent gastric surgery
(24/32, 75%) had gastroesophageal reflux disease (GERD)
documented as one of the primary clinical indications.892 The Journal of Thoracic and Cardiovascular SurgMany of these patients also had evidence of poor oral intake,
failure to thrive, or aspiration documented on swallow stud-
ies. Seven patients (22%) had a GT placed without a fundo-
plication for feeding intolerance or aspiration without
clinical evidence ofGERD, and 1 patient had aGTplaced af-
ter repair of a perforated esophagus. Therewas no difference
in midterm outcomes between the patients whose primary
indication for surgery was GERD versus others (P ¼ .8).
Preoperative evaluation before gastric surgery was highly
variable and determined by the cardiologist, cardiac surgeon,
pediatrician, and general surgeon involved with the patient.
The pediatric general surgeons generally requested an upper
gastrointestinal contrast study to document the gastric anat-
omy and normal gastric emptying before fundoplication,
whichwas performed in 25 of 32 patients (78%). A pHprobe
study was performed in 13 of 32 patients (40%); however,
many of these studies were inconclusive because of the
concurrent use of gastric acid suppressive therapy and a neg-
ative pH probe study did not preclude the performance of
a fundoplication based on clinical evidence of GERD. Eight
of the 32 patients (25%) had documented aspiration on
a swallow study before their gastric surgery. The majority
of gastric procedures were performed laparascopically (29/
32, 91%) with 1 open procedure and 2 percutaneous GTs.
The gastric surgery procedures were performed at a me-
dian age of 50 days (range, 30–726 days). Fifteen of theseery c April 2012
TABLE 2. Degree of association between preoperative variables and time to event survival probabilities
Characteristic 1-y survival 5-y survival 8-y survival P value HR (95% confidence interval)
Race
White (ref) 0.957 0.900 0.900 .28 1
 Black 0.972 0.912 0.810 0.92 (0.25–3.42)
 Hispanic 0.960 0.787 0.787 2.25 (0.75–6.72)
Gender
 Male (ref) 0.957 0.856 0.856 .36 1
 Female 0.967 0.934 0.879 0.62 (0.22–1.75)
Ventricle morphology
 Left (ref) 0.982 0.923 0.873 .55 1
 Right 0.955 0.880 0.880 1.31 (0.45–3.85)
 Both 0.900 0.750 0.750 2.46 (0.48–12.7)
Diagnosis
 HLHS (ref) 0.954 0.852 0.791 .36 1
 DILV 1.000 1.000 1.000 -
 Hypo RV/TA/PA 0.967 0.900 0.900 0.63 (0.17–2.29)
 Unbalanced CAVC 0.875 0.729 0.729 1.43 (0.31–6.57)
 Heterotaxy 1.00 0.857 0.857 0.69 (0.09–5.39)
 Other 0.960 0.960 0.960 0.25 (0.03–1.93)
HLHS
 No (ref) 0.966 0.912 0.912 .13 1
 Yes 0.954 0.852 0.791 2.06 (0.78–5.43)
Gestational age (SD) - - - .94 0.99 (0.78–1.25)
Birth weight (SD) - - - .053 0.48 (0.78–1.25)
Genetic syndrome (%)
 No (ref) 0.965 0.905 0.874 .54 1
 Yes 0.917 0.802 0.802 1.57 (0.36–6.90)
Fundo/GT
 No (ref) 0.967 0.921 0.921 1
 Yes 0.938 0.756 0.648 .003 4.29 (1.65–11.14)
Shown is transplant-free survival at several time points associated with each patient demographic and fundo/GT status.HLHS, Hypoplastic left heart syndrome;DILV, double-inlet
left ventricle; hypo RV/TA/PA, hypoplastic right ventricle with tricuspid or pulmonary atresia; CAVC, complete atrioventricular canal defect; fundo/GT, fundoplication or gastro-
stomy tube; ref, reference for HR comparisons.
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Dwere performed during the initial hospitalization for the
first-stage palliation, with the remainder performed as out-
patient, interstage procedures (11 between stage 1 and 2,
and 6 between stages 2 and 3). Analysis of these 3 groups
(fundoplication or GT performed at stage 1, between stages
1 and 2, and between stages 2 and 3) demonstrated no dif-
ference in transplant-free survival (P ¼ .8). There were no
operative or perioperative mortalities associated with the
gastric procedures.TABLE 3. Adjusted survival estimates with fundoplication/
gastrostomy tube modeled as a time-dependent covariate
Model
HR for fundo/
GT effect P value
Crude model (just fundo/GT effect) 4.29 (1.65–11.14) .003
Model with adjustment for HLHS,
ventricle morphology, birth weight
3.72 (1.28–10.78 .016
Full adjustment for all covariates 4.24 (1.34–13.42) .014
Three patient models. The first model represents the risk of transplant or mortality as
reflected by only the effect of fundo/GT regardless of other patient demographics. The
second model adjusts the HR for the stated patient demographics. The third model
adjusts the HR for all patient demographics. HR, Hazard ratio; GT, gastrostomy
tube; HLHS, hypoplastic left heart syndrom.
The Journal of Thoracic and CaTransplant-Free Survival Analysis
Table 2 shows the results of the bivariate survival analy-
sis. The only variables found to be significantly associated
with midterm transplant-free survival were the need for fun-
doplication or GT (P ¼ .003; HR, 4.29) and birth weight
(P ¼ .05).
Table 3 shows the multivariable survival analysis. The
HR for fundoplication or GTalone was 4.29 (P¼ .003). Af-
ter adjusting for the potential confounding effects of all sig-
nificant covariates, including HLHS diagnosis, ventricular
morphology, and birth weight, the HR was similar (HR,
3.72; P ¼ .016). The third model of the multivariable anal-
ysis adjusts the HR for all covariates (HR, 4.24; P ¼ .014).
As shown in Table 3, the HR for fundoplication or GTeffect
remains significant in all models. By Kaplan–Meier sur-
vival analysis, the need for early fundoplication or GT is
significantly associated with worse transplant-free survival
(Figure 1, P ¼ .004).
DISCUSSION
Children with single-ventricle heart disease who undergo
staged palliation experience a 2-phase hazard of death orrdiovascular Surgery c Volume 143, Number 4 893
FIGURE 1. Transplant-free survival. Survival of fundoplication/GTand non-fundoplication/GT cases over time. The y-axis is the survival probability, and
the x-axis demonstrates years of survival. Patients at risk for the 2 groups are shown along the x-axis.GI surgery indicates performance of a fundoplication or
GT within the first 2 years of life.
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Dtransplant with a peak risk associated with the first-stage
palliation, followed by long-term gradual attrition for
survivors of the first stage. Many published studies have in-
vestigated the risk factors associated with early mortality
after the Norwood procedure. These reports have identified
a wide variety of risk factors, including low birth weight,
cardiac anatomic subtypes (unbalanced atrioventricular ca-
nal or aortic atresia in HLHS), intraoperative variables, and
many others.4,7,8
The risk factors associated with the late hazard phase for
staged palliation have not been well defined. In 1997, Gen-
tles and colleagues3 reported the early and late outcomes for
the first 500 patients who underwent a Fontan procedure at
Children’s Hospital Boston between 1973 and 1991. They
identified only 2 risk factors associated with late outcome:
The presence of a pacemaker before the Fontan was
a poor prognostic indicator, whereas certain anatomic
subgroups were predictive of better outcomes (morphologic
left ventricle with normally related great vessels or single
right ventricle excluding heterotaxy and HLHS).
In a more recent study published in 2006, Mitchell and
colleagues2 at the Children’s Hospital of Philadelphia re-
ported their midterm results (9-year median follow-up)
for 332 survivors of the Fontan procedure performed be-
tween 1992 and 1999. The 10-year transplant-free survival
for this selected subgroup who had already survived
through the Fontan procedure was 93%. The only signifi-
cant risk factors for late attrition were the duration of the
aortic crossclamp during the Fontan procedure and the du-
ration of chest tube drainage in the postoperative period.
In comparison with these earlier reports, the current study
excluded children who died or received transplants before894 The Journal of Thoracic and Cardiovascular Surgthe second-stage palliation but included the second stage
and beyond. Although this is a somewhat arbitrary cutoff,
it correlates well with the reported demarcation between
the early and late hazard phases.
We found that cardiac anatomy and ventricular morphol-
ogy were associated with the need for fundoplication or GT,
with an increased incidence of fundoplication or GT in the
HLHS group (P ¼ .002), and a morphologic right ventricle
(P¼ .008). However, neither one of these variables affected
midterm transplant-free survival (P ¼ .4 and .6, respec-
tively), whereas the need for fundoplication or GTwas sig-
nificantly associated with poor outcome with an HR of 4.3
(P ¼ .003), and there was little change in this hazard after
correction for all covariates.
The question then becomes, what does this mean? Two
logical explanations leap immediately to mind. First, the
need for a fundoplication or GT early in life may serve as
a marker for other unmeasured variables that can affect
late survival as a palliated patient with single-ventricle dis-
ease. Patient populations who might be enriched in the fun-
doplication group are those with significant neurologic
impairment or an unidentified genetic syndrome. Either
one of these characteristics may be associated with an in-
creased risk of late failure. A second possibility is that the
presence of GERD early in life that is severe enough to
eventually require a fundoplicationmay result in pulmonary
soilage and an increased incidence of chronic pulmonary
disease, eventually predisposing this population to elevated
pulmonary vascular resistance and Fontan failure. Unfortu-
nately, this study cannot answer this critical question, but it
does point to the need for increased vigilance in this partic-
ular subgroup.ery c April 2012
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This study has several limitations. Although we have
been following this cohort prospectively, they do not repre-
sent a complete consecutive patient cohort. As a result, the
study suffers from the limitations of all retrospective studies
and unidentified selection biases. Also, the lack of a compre-
hensive genetic evaluation of all patients is a clear limitation
of the study. Finally, these patients are typical of the com-
plex congenital cardiac population in that they were hetero-
geneous with regard to the indications for gastric surgery
and the timing of these procedures. Because there were
many uncontrolled clinical factors, this study can only dem-
onstrate an association between the need for gastric surgery
early in life and midterm outcomes. We can make no state-
ments regarding causality.CONCLUSIONS
Patients with single-ventricle disease who require early
fundoplication or a GT are at increased risk of midtermThe Journal of Thoracic and Cafailure of staged palliation. The implications of this finding
are not entirely clear, but this patient population may benefit
from increased surveillance.
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